Belfer Institute for Applied Cancer Science, Harvard Medical School, Boston, Massachusetts 02115, USA.
Genes Dev. 2012 Jul 1;26(13):1459-72. doi: 10.1101/gad.189001.112.
Multidimensional cancer genome analysis and validation has defined Quaking (QKI), a member of the signal transduction and activation of RNA (STAR) family of RNA-binding proteins, as a novel glioblastoma multiforme (GBM) tumor suppressor. Here, we establish that p53 directly regulates QKI gene expression, and QKI protein associates with and leads to the stabilization of miR-20a; miR-20a, in turn, regulates TGFβR2 and the TGFβ signaling network. This pathway circuitry is substantiated by in silico epistasis analysis of its components in the human GBM TCGA (The Cancer Genome Atlas Project) collection and by their gain- and loss-of-function interactions in in vitro and in vivo complementation studies. This p53-QKI-miR-20a-TGFβ pathway expands our understanding of the p53 tumor suppression network in cancer and reveals a novel tumor suppression mechanism involving regulation of specific cancer-relevant microRNAs.
多维癌症基因组分析和验证将 Quaking(QKI)确定为信号转导和 RNA 激活(STAR)家族的 RNA 结合蛋白的新胶质母细胞瘤(GBM)肿瘤抑制因子。在这里,我们确定 p53 直接调节 QKI 基因表达,QKI 蛋白与 miR-20a 结合并导致其稳定;miR-20a 反过来调节 TGFβR2 和 TGFβ 信号网络。通过对人类 GBM TCGA(癌症基因组图谱项目)集合中其成分的计算机上位点分析以及体外和体内互补研究中它们的获得和丧失功能相互作用,证实了该途径电路。该 p53-QKI-miR-20a-TGFβ 途径扩展了我们对癌症中 p53 肿瘤抑制网络的理解,并揭示了涉及调节特定癌症相关 microRNAs 的新型肿瘤抑制机制。